James Cassella
Net worth: - $ as of 2026-05-30
Net worth: - $ as of 2026-05-30
James V.
Cassella is currently Chief Development Officer at Trevi Therapeutics, Inc. since 2024.
Formerly, Chief Development Officer at Sun Pharmaceutical Industries, Inc. from 2023 to 2024.
Chief Development Officer & Senior Vice President at Concert Pharmaceuticals, Inc. from 2015 to 2023.
CSO, Executive VP-Research & Development at Alexza Pharmaceuticals, Inc. from 2013 to 2015.
Senior VP-Clinical Research & Development at Neurogen Corp.
from 1989 to 2004.
Assistant Professor at Oberlin College.
Education includes a doctorate from Dartmouth College and an undergraduate degree from the University of New Haven.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-05 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 2024-09-29 |
| Companies | Position | End |
|---|---|---|
Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2024-08-31 |
| CONCERT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2023-02-28 |
| ALEXZA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2015-01-28 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Chief Tech/Sci/R&D Officer | 2004-05-31 |
Oberlin College
Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Oberlin College
Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Haven
University of New Haven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Select your edition
All financial news and data tailored to specific country editions